Oblender M, Carpentieri U
Pediatric Department, University of Texas Medical Branch, Galveston 77550.
Anticancer Res. 1990 Jan-Feb;10(1):123-7.
The activity of ribonucleotide reductase (RR) extracted from normal and leukemic human lymphocytes was assessed. The activity of the enzyme was five times higher in leukemic cells than in normal lymphocytes. Fe and Cu stimulated and Zn inhibited RR activity in both types of cells. Zn also partially reduced the stimulatory effects of Fe and Cu. Deferoxamine (DFX) alone inhibited the activity of the enzyme and enhanced a similar inhibitory action of hydroxyurea (HU). In both cases the inhibitory effects were reversed by Fe and Cu, but not Zn. These findings suggest that: 1) Fe, Cu and Zn may modulate RR activity in vitro and their action is related and interdependent. 2) DFX alone may inhibit RR activity. 3) DFX enhances HU effect on leukemic cells. 4) The effects of both inhibitors may be modified by trace metals.
对从正常人和白血病患者淋巴细胞中提取的核糖核苷酸还原酶(RR)的活性进行了评估。该酶在白血病细胞中的活性比正常淋巴细胞高五倍。铁(Fe)和铜(Cu)刺激RR活性,而锌(Zn)抑制两种细胞类型中的RR活性。锌还部分降低了铁和铜的刺激作用。去铁胺(DFX)单独抑制该酶的活性,并增强了羟基脲(HU)的类似抑制作用。在这两种情况下,铁和铜可逆转抑制作用,但锌不能。这些发现表明:1)铁、铜和锌可能在体外调节RR活性,且它们的作用相关且相互依赖。2)单独使用DFX可能抑制RR活性。3)DFX增强HU对白血病细胞的作用。4)两种抑制剂的作用可能会被微量元素改变。